We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
Eyenovia has launched clobetasol propionate ophthalmic suspension 0.05% (Clobetasol) for the treatment of post-operative inflammation and pain following ocular surgery in the United States.
